Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib in Pre-Surgical Breast Cancer
NCT01410708Phase 2Withdrawn
- Sponsor
- American Health Staffing Group
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dasatinib in breast cancer, sponsored by American Health Staffing Group. Status: withdrawn.
02
Drugs
dasatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01410708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01410708.